Down in Pugwash Station I hear they even have peep holes for regulars as yourself.
I wish Chippy gave me a peep as to where all my money went.
I think the opt-in or out decision will be made with current trial data already in. If it's as good as Dr. T says it is Janssen will want to wrap things up quickly. IMET represents an an entire class of new first in line drugs.
CPXX went up 10x in one month recently with a similar synopsis as GERN on their phase 3 AML trial drug, albeit on far less shares and a 5 not 23% short position
that's the plan Stan. Sucks for us investors with our capital tied up in this enigma babushka doll wrapped in a cloak, hidden within a riddle.
almost sounds like Our Lady of Zucchini at the temple of Zuchs in the CA central valley close to Menlo Park
well known for their zucchini bread & fries sacramento.
"some kinda murky Sachs deal" Spot on...maybe that's all in the fine print of the contract we aren't privy to. Something smells in in the state of Denmark and it ain't the red herring.
CPXX another J&J buyout contender ;
SP $16 outstanding # shares 38mil, short interest 5 % one drug in phase 3 trial (limited response)
GERN SP $3.30 outstanding # number of shares diluted now to 158mil, short interest 30% one drug in 3 separate indications trial ( one in phase 3...with possibly much better clinical data results)
take your pick. CPXX SP was $1.68 a month ago. GERN's stayed about the same.
come on Joko u can do better than that, give us a bidding war that would drive Geron's price up to unreasonable levels
Surprised Dr. Kevorkian didn't make the list but then holding GERN has been very inhumane.
hang on to that property..... fellow Cuban realty comrades have made a killing so far.
"Shares of the pharmaceutical company were crushed on Thursday, closing down 44 percent, after the FDA treview panel maintained a negative outlook on Sarepta's drug for a rare muscular degeneration disorder.
According to the agenda released Friday however, the committee will vote on whether eteplirsen, Sarepta's drug, is effective for the treatment of Duchenne's muscular dystrophy." Shares gained on this news; shares back up 40% on Friday. Makes you wonder if in fact the FDA review committee is on the take or they operate their own hedge fund like SP manipulation scam. Nice trading environment brought you by the FDA.
the 1ST run up to Dec 5 was ASH expectations. The second run up was an orchestrated fake head to cover up a profit taking sell off.
Erich he said look to the expanding trial updates for indications in other words
he also said Janssen would be in control of the interim data info update and or opt-in decision which would both be major SP catalysts . This long before your interpretation as "nothing happening till 2017 & 2018".
"seriously im reaching a point where this isnt funny anymore...you just wont let this go. I'm prettty sure that what you are doing could be pretttty illegal. Have you seen the wolf of wallstreet? I mean, seriously who do you work for that you are SOOOO obsessed with pumping this stock up? Referring to you madefor2016 among others. btw not a short and dont give a flying poop about this dog poop stock. I am not even in this trash. Trust me, I know trash when I see it."